(PROJECT 3) Project 3 focuses on the pleiotropic damage response known as cellular senescence. The senescence response is an essentially permanent arrest of cell proliferation, accompanied by phenotypic changes, including the development of a senescence-associated secretory phenotype (SASP). The SASP entails the robust expression and secretion of a suite of pro-inflammatory cytokines, chemokines, growth factors and proteases. We have now firmly established that the SASP is a response to genomic/epigenomic damage, and that it can profoundly alter tissue microenvironments and promote both degenerative and hyperplastic phenotypes associated with aging. In this renewal application, we will use human and mouse cell cultures and mouse models to critically determine the role of cellular senescence in damage-induced aging phenotypes, and more thoroughly explore the costs and benefits of the senescence response in the context of aging. We will also determine the role of longevity mediators that have been and will be studied within the PPG in modulating various senescent cell phenotypes.
Our specific aims are designed to answer the following questions: To what extent and under which circumstances do senescent cells contribute to aging phenotypes? To what extent do the longevity-associated genes studied in the PPG alter the phenotype(s) of senescent cells? And to what extent and under what circumstances do senescent cells benefit the organism, specifically by promoting wound healing? Our proposed experiments will provide a critical analysis of the extent to which senescent cells drive aging phenotypes, important information on how senescent phenotypes are regulated, and insights into novel benefits of the senescence response. In addition to generating important basic knowledge, the experiments will also provide a framework for developing and understanding potential interventions into aging phenotypes.
(PROJECT 3) Damage to the genome is thought to cause many of the manifestations and diseases of aging. This project will determine how the cellular damage response known as cellular senescence drives aging, and will provide proof of principle that eliminating senescent cells can prevent or reverse damage-induced aging phenotypes.
|Han, Jeehae; Atzmon, Gil; Barzilai, Nir et al. (2015) Genetic variation in Sirtuin 1 (SIRT1) is associated with lipid profiles but not with longevity in Ashkenazi Jews. Transl Res 165:480-1|
|Raj, Divya D A; Jaarsma, Dick; Holtman, Inge R et al. (2014) Priming of microglia in a DNA-repair deficient model of accelerated aging. Neurobiol Aging 35:2147-60|
|Choi, Yong Jun; Li, Han; Son, Mi Young et al. (2014) Deletion of individual Ku subunits in mice causes an NHEJ-independent phenotype potentially by altering apurinic/apyrimidinic site repair. PLoS One 9:e86358|
|Barnhoorn, Sander; Uittenboogaard, Lieneke M; Jaarsma, Dick et al. (2014) Cell-autonomous progeroid changes in conditional mouse models for repair endonuclease XPG deficiency. PLoS Genet 10:e1004686|
|Akman, Kemal; Haaf, Thomas; Gravina, Silvia et al. (2014) Genome-wide quantitative analysis of DNA methylation from bisulfite sequencing data. Bioinformatics 30:1933-4|
|Jung, Hwa Jin; Suh, Yousin (2014) Circulating miRNAs in ageing and ageing-related diseases. J Genet Genomics 41:465-72|
|Campisi, Judith; Robert, Ladislas (2014) Cell senescence: role in aging and age-related diseases. Interdiscip Top Gerontol 39:45-61|
|Derks, Kasper W J; Hoeijmakers, Jan H J; Pothof, Joris (2014) The DNA damage response: the omics era and its impact. DNA Repair (Amst) 19:214-20|
|Campisi, Judith (2014) Cell biology: The beginning of the end. Nature 505:35-6|
|Reiling, Erwin; Dollé, Martijn E T; Youssef, Sameh A et al. (2014) The progeroid phenotype of Ku80 deficiency is dominant over DNA-PKCS deficiency. PLoS One 9:e93568|
Showing the most recent 10 out of 155 publications